Loading...
Header Logo
Keywords
Last Name
Institution

JAMES WELSH

TitleAssociate Professor
InstitutionMD Anderson
DepartmentRadiation Oncology
vCardDownload vCard

    Collapse ORNG Applications 
    Collapse Verify Publications

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Welsh JW, Tang C, de Groot P, Naing A, Hess KR, Heymach JV, Papadimitrakopoulou VA, Cushman TR, Subbiah V, Chang JY, Simon GR, Ramapriyan R, Barsoumian HB, Menon H, Cortez MA, Massarelli E, Nguyen Q, Sharma P, Allison JP, Diab A, Verma V, Raju U, Shaaban SG, Dadu R, Cabanillas ME, Wang K, Anderson C, Gomez DR, Hahn S, Komaki R, Hong DS. Phase II Trial of Ipilimumab with Stereotactic Radiation Therapy for Metastatic Disease: Outcomes, Toxicities, and Low-Dose Radiation-Related Abscopal Responses. Cancer Immunol Res. 2019 Oct 28. PMID: 31658994.
      View in: PubMed
    2. Welsh JW, Heymach JV, Chen D, Verma V, Cushman TR, Hess KR, Shroff G, Tang C, Skoulidis F, Jeter M, Menon H, Nguyen QN, Chang JY, Altan M, Papadimitrakopoulou VA, Simon GR, Raju U, Byers L, Glisson B. Phase I Trial of Pembrolizumab and Radiation Therapy after Induction Chemotherapy for Extensive-Stage Small Cell Lung Cancer. J Thorac Oncol. 2019 Oct 09. PMID: 31605794.
      View in: PubMed
    3. Kang J, Ning MS, Feng H, Li H, Bahig H, Brooks ED, Welsh JW, Ye R, Miao H, Chang JY. Predicting 5-Year Progression and Survival Outcomes for Early-Stage Non-Small Cell Lung Cancer Treated with Stereotactic Ablative Radiotherapy: Development and Validation of Robust Prognostic Nomograms. Int J Radiat Oncol Biol Phys. 2019 Oct 03. PMID: 31586665.
      View in: PubMed
    4. Choi JH, Lee D, O'Connor L, Chalup S, Welsh JS, Dowling J, Greer PB. Bulk Anatomical Density Based Dose Calculation for Patient-Specific Quality Assurance of MRI-Only Prostate Radiotherapy. Front Oncol. 2019; 9:997. PMID: 31632921.
      View in: PubMed
    5. Caetano MS, Younes AI, Barsoumian HB, Quigley M, Menon H, Gao C, Spires T, Reilly TP, Cadena AP, Cushman TR, Schoenhals JE, Li A, Nguyen QN, Cortez MA, Welsh JW. Triple Therapy with MerTK and PD1 Inhibition Plus Radiotherapy Promotes Abscopal Antitumor Immune Responses. Clin Cancer Res. 2019 Sep 20. PMID: 31540976.
      View in: PubMed
    6. Chen D, Menon H, Verma V, Seyedin SN, Ajani JA, Hofstetter WL, Nguyen QN, Chang JY, Gomez DR, Amini A, Swisher SG, Blum MA, Younes AI, Barsoumian HB, Erasmus JJ, Lee JH, Bhutani MS, Hess KR, Minsky BD, Welsh JW. Results of a Phase 1/2 Trial of Chemoradiotherapy With Simultaneous Integrated Boost of Radiotherapy Dose in Unresectable Locally Advanced Esophageal Cancer. JAMA Oncol. 2019 Sep 17. PMID: 31529018.
      View in: PubMed
    7. Menon H, Chen D, Ramapriyan R, Verma V, Barsoumian HB, Cushman TR, Younes AI, Cortez MA, Erasmus JJ, de Groot P, Carter BW, Hong DS, Glitza IC, Ferrarotto R, Altan M, Diab A, Chun SG, Heymach JV, Tang C, Nguyen QN, Welsh JW. Influence of low-dose radiation on abscopal responses in patients receiving high-dose radiation and immunotherapy. J Immunother Cancer. 2019 Sep 04; 7(1):237. PMID: 31484556.
      View in: PubMed
    8. Verma V, Ludmir EB, Mesko SM, Brooks ED, Augustyn A, Milano MT, Lin SH, Chang JY, Welsh JW. Commercial Insurance Coverage of Advanced Radiation Therapy Techniques Compared With American Society for Radiation Oncology Model Policies. Pract Radiat Oncol. 2019 Aug 22. PMID: 31446147.
      View in: PubMed
    9. Siegel JA, Brooks AL, Fisher DR, Zanzonico PB, Doss M, O'Connor MK, Silberstein EB, Welsh JS, Greenspan BS. A Critical Assessment of the Linear No-Threshold Hypothesis: Its Validity and Applicability for Use in Risk Assessment and Radiation Protection. Clin Nucl Med. 2019 Jul; 44(7):521-525. PMID: 31107746.
      View in: PubMed
    10. Nguyen QN, Chun SG, Chow E, Komaki R, Liao Z, Zacharia R, Szeto BK, Welsh JW, Hahn SM, Fuller CD, Moon BS, Bird JE, Satcher R, Lin PP, Jeter M, O'Reilly MS, Lewis VO. Single-Fraction Stereotactic vs Conventional Multifraction Radiotherapy for Pain Relief in Patients With Predominantly Nonspine Bone Metastases: A Randomized Phase 2 Trial. JAMA Oncol. 2019 Jun 01; 5(6):872-878. PMID: 31021390.
      View in: PubMed
    11. Gomez DR, Tang C, Zhang J, Blumenschein GR, Hernandez M, Lee JJ, Ye R, Palma DA, Louie AV, Camidge DR, Doebele RC, Skoulidis F, Gaspar LE, Welsh JW, Gibbons DL, Karam JA, Kavanagh BD, Tsao AS, Sepesi B, Swisher SG, Heymach JV. Local Consolidative Therapy Vs. Maintenance Therapy or Observation for Patients With Oligometastatic Non-Small-Cell Lung Cancer: Long-Term Results of a Multi-Institutional, Phase II, Randomized Study. J Clin Oncol. 2019 Jun 20; 37(18):1558-1565. PMID: 31067138.
      View in: PubMed
    12. Elhammali A, Blanchard P, Yoder A, Liao Z, Zhang X, Ronald Zhu X, Allen PK, Jeter M, Welsh J, Nguyen QN. Clinical outcomes after intensity-modulated proton therapy with concurrent chemotherapy for inoperable non-small cell lung cancer. Radiother Oncol. 2019 Jul; 136:136-142. PMID: 31015115.
      View in: PubMed
    13. Bloom BC, Augustyn A, Pezzi TA, Menon H, Mayo LL, Shah SJ, Schwartz DL, Chmura SJ, Johnson FM, Welsh JW, Chun SG. Rescue of Immunotherapy-Refractory Metastatic Merkel Cell Carcinoma With Conventionally Fractionated Radiotherapy and Concurrent Pembrolizumab. Front Oncol. 2019; 9:223. PMID: 31024834.
      View in: PubMed
    14. Cortez MA, Anfossi S, Ramapriyan R, Menon H, Atalar SC, Aliru M, Welsh J, Calin GA. Role of miRNAs in immune responses and immunotherapy in cancer. Genes Chromosomes Cancer. 2019 04; 58(4):244-253. PMID: 30578699.
      View in: PubMed
    15. Li A, Barsoumian HB, Schoenhals JE, Caetano MS, Wang X, Menon H, Valdecanas DR, Niknam S, Younes AI, Cortez MA, Welsh JW. IDO1 Inhibition Overcomes Radiation-Induced "Rebound Immune Suppression" by Reducing Numbers of IDO1-Expressing Myeloid-Derived Suppressor Cells in the Tumor Microenvironment. Int J Radiat Oncol Biol Phys. 2019 Jul 15; 104(4):903-912. PMID: 30905636.
      View in: PubMed
    16. Li H, Verma V, Brooks ED, Feng L, Zhang T, Welsh JW, Lin SH, Gomez D, Gandhi S, Heymach JV, Chang JY. Impact of Corticosteroid Administration on Outcomes Following Stereotactic Ablative Radiotherapy for Non-small-cell Lung Cancer. Clin Lung Cancer. 2019 07; 20(4):e480-e488. PMID: 31078421.
      View in: PubMed
    17. Menon H, Ramapriyan R, Cushman TR, Verma V, Kim HH, Schoenhals JE, Atalar C, Selek U, Chun SG, Chang JY, Barsoumian HB, Nguyen QN, Altan M, Cortez MA, Hahn SM, Welsh JW. Role of Radiation Therapy in Modulation of the Tumor Stroma and Microenvironment. Front Immunol. 2019; 10:193. PMID: 30828330.
      View in: PubMed
    18. Verma V, Haque W, Cushman TR, Lin C, Simone CB, Chang JY, McClelland S, Welsh JW. Racial and Insurance-related Disparities in Delivery of Immunotherapy-type Compounds in the United States. J Immunother. 2019 Feb/Mar; 42(2):55-64. PMID: 30628924.
      View in: PubMed
    19. Suzuki R, Wei X, Allen PK, Welsh JW, Cox JD, Komaki R, Lin SH. Outcomes of re-irradiation for brain recurrence after prophylactic or therapeutic whole-brain irradiation for small cell lung Cancer: a retrospective analysis. Radiat Oncol. 2018 Dec 29; 13(1):258. PMID: 30594213.
      View in: PubMed
    20. Verma V, Sprave T, Haque W, Simone CB, Chang JY, Welsh JW, Thomas CR. A systematic review of the cost and cost-effectiveness studies of immune checkpoint inhibitors. J Immunother Cancer. 2018 11 23; 6(1):128. PMID: 30470252.
      View in: PubMed
    21. Solanki AA, Bossi A, Efstathiou JA, Lock D, Mondini M, Ramapriyan R, Welsh J, Kang J. Combining Immunotherapy with Radiotherapy for the Treatment of Genitourinary Malignancies. Eur Urol Oncol. 2019 Feb; 2(1):79-87. PMID: 30929848.
      View in: PubMed
    22. Ramapriyan R, Caetano MS, Barsoumian HB, Mafra ACP, Zambalde EP, Menon H, Tsouko E, Welsh JW, Cortez MA. Altered cancer metabolism in mechanisms of immunotherapy resistance. Pharmacol Ther. 2019 03; 195:162-171. PMID: 30439456.
      View in: PubMed
    23. Verma V, Cushman TR, Tang C, Welsh JW. Toxicity of radiation and immunotherapy combinations. Adv Radiat Oncol. 2018 Oct-Dec; 3(4):506-511. PMID: 30370349.
      View in: PubMed
    24. Cai L, Welsh JS, Pennington CW. Letter by Cai et al Regarding Article, "Exposure to Low-Dose Ionizing Radiation From Cardiac Procedures and Malignancy Risk in Adults With Congenital Heart Disease". Circulation. 2018 09 25; 138(13):1377-1378. PMID: 30354422.
      View in: PubMed
    25. Schoenhals JE, Cushman TR, Barsoumian HB, Li A, Cadena AP, Niknam S, Younes AI, Caetano MDS, Cortez MA, Welsh JW. Anti-glucocorticoid-induced Tumor Necrosis Factor-Related Protein (GITR) Therapy Overcomes Radiation-Induced Treg Immunosuppression and Drives Abscopal Effects. Front Immunol. 2018; 9:2170. PMID: 30294332.
      View in: PubMed
    26. Suzuki R, Wei X, Allen PK, Welsh JW, Cox JD, Komaki R, Lin SH. Twice-daily Thoracic Radiotherapy for Limited-stage Small-cell Lung Cancer Does Not Increase the Incidence of Acute Severe Esophagitis. Clin Lung Cancer. 2018 11; 19(6):e885-e891. PMID: 30197263.
      View in: PubMed
    27. Brooks ED, Sun B, Feng L, Verma V, Zhao L, Gomez DR, Liao Z, Jeter M, O'Reilly M, Welsh JW, Nguyen QN, Erasmus JJ, Eapen G, Ahrar K, Antonoff MB, Hahn SM, Heymach JV, Rice DC, Chang JY. Association of Long-term Outcomes and Survival With Multidisciplinary Salvage Treatment for Local and Regional Recurrence After Stereotactic Ablative Radiotherapy for Early-Stage Lung Cancer. JAMA Netw Open. 2018 08 03; 1(4):e181390. PMID: 30646121.
      View in: PubMed
    28. Cushman TR, Caetano MS, Welsh JW, Verma V. Overview of ongoing clinical trials investigating combined radiotherapy and immunotherapy. Immunotherapy. 2018 08; 10(10):851-0. PMID: 30073899.
      View in: PubMed
    29. Pezzi TA, Schwartz DL, Mohamed ASR, Welsh JW, Komaki RU, Hahn SM, Sepesi B, Pezzi CM, Fuller CD, Chun SG. Barriers to Combined-Modality Therapy for Limited-Stage Small Cell Lung Cancer. JAMA Oncol. 2018 08 01; 4(8):e174504. PMID: 29302695.
      View in: PubMed
    30. Cadena AP, Cushman TR, Welsh JW. Glycosylation and Antitumor Immunity. Int Rev Cell Mol Biol. 2019; 343:111-127. PMID: 30712671.
      View in: PubMed
    31. Dorta-Estremera S, Colbert LE, Nookala SS, Yanamandra AV, Yang G, Delgado A, Mikkelson M, Eifel P, Jhingran A, Lilie LL, Welsh J, Schmeler K, Sastry JK, Klopp A. Kinetics of Intratumoral Immune Cell Activation During Chemoradiation for Cervical Cancer. Int J Radiat Oncol Biol Phys. 2018 11 01; 102(3):593-600. PMID: 30017792.
      View in: PubMed
    32. Suzuki R, Wei X, Allen PK, Welsh JW, Komaki R, Lin SH. Hematologic variables associated with brain failure in patients with small-cell lung cancer. Radiother Oncol. 2018 09; 128(3):505-512. PMID: 29907337.
      View in: PubMed
    33. Niknam S, Barsoumian HB, Schoenhals JE, Jackson HL, Yanamandra N, Caetano MS, Li A, Younes AI, Cadena A, Cushman TR, Chang JY, Nguyen QN, Gomez DR, Diab A, Heymach JV, Hwu P, Cortez MA, Welsh JW. Radiation Followed by OX40 Stimulation Drives Local and Abscopal Antitumor Effects in an Anti-PD1-Resistant Lung Tumor Model. Clin Cancer Res. 2018 11 15; 24(22):5735-5743. PMID: 29784675.
      View in: PubMed
    34. Li A, Barsoumian HB, Schoenhals JE, Cushman TR, Caetano MS, Wang X, Valdecanas DR, Niknam S, Younes AI, Li G, Woodward WA, Cortez MA, Welsh JW. Indoleamine 2,3-dioxygenase 1 inhibition targets anti-PD1-resistant lung tumors by blocking myeloid-derived suppressor cells. Cancer Lett. 2018 09 01; 431:54-63. PMID: 29746927.
      View in: PubMed
    35. Benveniste MF, Welsh J, Viswanathan C, Shroff GS, Betancourt Cuellar SL, Carter BW, Marom EM. Lung Cancer: Posttreatment Imaging: Radiation Therapy and Imaging Findings. Radiol Clin North Am. 2018 May; 56(3):471-483. PMID: 29622079.
      View in: PubMed
    36. Verma V, Cushman TR, Selek U, Tang C, Welsh JW. Safety of Combined Immunotherapy and Thoracic Radiation Therapy: Analysis of 3 Single-Institutional Phase I/II Trials. Int J Radiat Oncol Biol Phys. 2018 08 01; 101(5):1141-1148. PMID: 30012526.
      View in: PubMed
    37. Rashed I, Welsh JS. Diagnosis and Treatment of Hidradenitis Suppurativa. JAMA. 2018 04 17; 319(15):1618. PMID: 29677296.
      View in: PubMed
    38. Okunieff P, Casey-Sawicki K, Lockney NA, Hoppe BS, Enderling H, Pinnix C, Welsh J, Krishnan S, Yothers G, Brown M, Knox S, Bristow R, Spellman P, Mitin T, Nabavizadeh N, Jaboin J, Manning HC, Feng F, Galbraith S, Solanki AA, Harkenrider MM, Tuli R, Decker RH, Finkelstein SE, Hsu CC, Ha CS, Jagsi R, Shumway D, Daly M, Wang TJC, Fitzgerald TJ, Laurie F, Marshall DT, Raben D, Constine L, Thomas CR, Kachnic LA. Report from the SWOG Radiation Oncology Committee: Research Objectives Workshop 2017. Clin Cancer Res. 2018 08 01; 24(15):3500-3509. PMID: 29661779.
      View in: PubMed
    39. Shah MY, Ferracin M, Pileczki V, Chen B, Redis R, Fabris L, Zhang X, Ivan C, Shimizu M, Rodriguez-Aguayo C, Dragomir M, Van Roosbroeck K, Almeida MI, Ciccone M, Nedelcu D, Cortez MA, Manshouri T, Calin S, Muftuoglu M, Banerjee PP, Badiwi MH, Parker-Thornburg J, Multani A, Welsh JW, Estecio MR, Ling H, Tomuleasa C, Dima D, Yang H, Alvarez H, You MJ, Radovich M, Shpall E, Fabbri M, Rezvani K, Girnita L, Berindan-Neagoe I, Maitra A, Verstovsek S, Fodde R, Bueso-Ramos C, Gagea M, Manero GG, Calin GA. Cancer-associated rs6983267 SNP and its accompanying long noncoding RNA CCAT2 induce myeloid malignancies via unique SNP-specific RNA mutations. Genome Res. 2018 04; 28(4):432-447. PMID: 29567676.
      View in: PubMed
    40. Kim CR, Kim B, Ning MS, Reddy JP, Liao Z, Tang C, Welsh JW, Mott FE, Shih YT, Gomez DR. Cost Analysis of PET/CT Versus CT as Surveillance for Stage III Non-Small-Cell Lung Cancer After Definitive Radiation Therapy. Clin Lung Cancer. 2018 07; 19(4):e517-e528. PMID: 29685701.
      View in: PubMed
    41. Mortazavi SMJ, Bevelacqua JJ, Fornalski KW, Welsh J, Doss M. Comments on "Space: The Final Frontier-Research Relevant to Mars". Health Phys. 2018 03; 114(3):344-345. PMID: 29360711.
      View in: PubMed
    42. Mortazavi SMJ, Bevelacqua JJ, Fornalski KW, Pennigton CW, Welsh J, Janiak MK, Dobrzynski L, Doss M. Letter to the Editor (August 24, 2017) concerning the paper "Occupational exposure to radon for underground tourist routes in Poland: Doses to lung and the risk of developing lung cancer". Int J Occup Med Environ Health. 2018 10 24; 31(5):703-706. PMID: 29416140.
      View in: PubMed
    43. Suzuki R, Lin SH, Wei X, Allen PK, Welsh JW, Byers LA, Komaki R. Prognostic significance of pretreatment total lymphocyte count and neutrophil-to-lymphocyte ratio in extensive-stage small-cell lung cancer. Radiother Oncol. 2018 Mar; 126(3):499-505. PMID: 29398150.
      View in: PubMed
    44. Cushman TR, Gomez D, Kumar R, Likacheva A, Chang JY, Cadena AP, Paris S, Welsh JW. Combining radiation plus immunotherapy to improve systemic immune response. J Thorac Dis. 2018 Feb; 10(Suppl 3):S468-S479. PMID: 29593892.
      View in: PubMed
    45. Siegel JA, Pennington CW, Sacks B, Welsh JS. The Birth of the Illegitimate Linear No-Threshold Model: An Invalid Paradigm for Estimating Risk Following Low-dose Radiation Exposure. Am J Clin Oncol. 2018 02; 41(2):173-177. PMID: 26535990.
      View in: PubMed
    46. Aliru ML, Schoenhals JE, Venkatesulu BP, Anderson CC, Barsoumian HB, Younes AI, K Mahadevan LS, Soeung M, Aziz KE, Welsh JW, Krishnan S. Radiation therapy and immunotherapy: what is the optimal timing or sequencing? Immunotherapy. 2018 02 01; 10(4):299-316. PMID: 29421979.
      View in: PubMed
    47. Tang C, Hobbs B, Amer A, Li X, Behrens C, Canales JR, Cuentas EP, Villalobos P, Fried D, Chang JY, Hong DS, Welsh JW, Sepesi B, Court L, Wistuba II, Koay EJ. Development of an Immune-Pathology Informed Radiomics Model for Non-Small Cell Lung Cancer. Sci Rep. 2018 01 31; 8(1):1922. PMID: 29386574.
      View in: PubMed
    48. Cadena A, Cushman TR, Anderson C, Barsoumian HB, Welsh JW, Cortez MA. Radiation and Anti-Cancer Vaccines: A Winning Combination. Vaccines (Basel). 2018 Jan 30; 6(1). PMID: 29385680.
      View in: PubMed
    49. Siegel JA, Sacks B, Pennington CW, Welsh JS. Reply: DNA Repair After Exposure to Ionizing Radiation Is Not Error-Free. J Nucl Med. 2018 02; 59(2):349. PMID: 29301929.
      View in: PubMed
    50. Cuttler JM, Mortazavi SMJ, Welsh JS, Doss M. Re: "Low-Dose Childhood Radiation Effects to the Thyroid Follow a Linear Dose-Response Trend and Persist Even 45+ Years After Exposure" (Clin Thyroidol 2017;29:235-236). Thyroid. 2018 05; 28(5):679-680. PMID: 29132249.
      View in: PubMed
    51. An Y, Jiang W, Kim BYS, Qian JM, Tang C, Fang P, Logan J, D'Souza NM, Haydu LE, Wang XA, Hess KR, Kluger H, Glitza IC, Mahajan A, Welsh JW, Lin SH, Yu JB, Davies MA, Hwu P, Sulman EP, Brown PD, Chiang VLS, Li J. Stereotactic radiosurgery of early melanoma brain metastases after initiation of anti-CTLA-4 treatment is associated with improved intracranial control. Radiother Oncol. 2017 10; 125(1):80-88. PMID: 28916225.
      View in: PubMed
    52. Engel S, Lischalk JW, Barry P, Hopkins S, Welsh JS, Fernandez E, Mundt AJ. Radiation Oncology Resident Mentorship: Results of a Resident-Coordinated Mentorship Program. J Am Coll Radiol. 2017 12; 14(12):1607-1610. PMID: 28865723.
      View in: PubMed
    53. Kono M, Allen PK, Lin SH, Wei X, Jeter MD, Welsh JW, Cox JD, Komaki R. Incidence of Second Malignancy after Successful Treatment of Limited-Stage Small-Cell Lung Cancer and Its Effects on Survival. J Thorac Oncol. 2017 11; 12(11):1696-1703. PMID: 28804012.
      View in: PubMed
    54. Chang JY, Verma V, Li M, Zhang W, Komaki R, Lu C, Allen PK, Liao Z, Welsh J, Lin SH, Gomez D, Jeter M, O'Reilly M, Zhu RX, Zhang X, Li H, Mohan R, Heymach JV, Vaporciyan AA, Hahn S, Cox JD. Proton Beam Radiotherapy and Concurrent Chemotherapy for Unresectable Stage III Non-Small Cell Lung Cancer: Final Results of a Phase 2 Study. JAMA Oncol. 2017 08 10; 3(8):e172032. PMID: 28727865.
      View in: PubMed
    55. Welsh JS, Hentz C. Androgen Deprivation Therapy and Subsequent Dementia. JAMA Oncol. 2017 07 01; 3(7):1000-1001. PMID: 28472302.
      View in: PubMed
    56. Mortazavi S, Bevelacqua JJ, Corrice L, Dobrzynski L, Feinendegen LE, Miller ML, Sacks B, Ulsh B, Pennington CW, Welsh J, Doss M. Comment on "Chromosomal Aberrations in Large Japanese Field Mice (Apodemus speciosus) Captured Near Fukushima Dai-ichi Nuclear Power Plant". Environ Sci Technol. 2017 07 18; 51(14):8196-8197. PMID: 28654249.
      View in: PubMed
    57. Davuluri R, Jiang W, Fang P, Xu C, Komaki R, Gomez DR, Welsh J, Cox JD, Crane CH, Hsu CC, Lin SH. Lymphocyte Nadir and Esophageal Cancer Survival Outcomes After Chemoradiation Therapy. Int J Radiat Oncol Biol Phys. 2017 09 01; 99(1):128-135. PMID: 28816138.
      View in: PubMed
    58. Sura K, Lischalk JW, Leckie J, Welsh JS, Mundt AJ, Fernandez E. Webinar-Based Contouring Education for Residents. J Am Coll Radiol. 2017 Aug; 14(8):1074-1079.e3. PMID: 28551341.
      View in: PubMed
    59. Siegel JA, Sacks B, Pennington CW, Welsh JS. Dose Optimization to Minimize Radiation Risk for Children Undergoing CT and Nuclear Medicine Imaging Is Misguided and Detrimental. J Nucl Med. 2017 06; 58(6):865-868. PMID: 28490467.
      View in: PubMed
    60. Schoenhals JE, Seyedin SN, Anderson C, Brooks ED, Li YR, Younes AI, Niknam S, Li A, Barsoumian HB, Cortez MA, Welsh JW. Uncovering the immune tumor microenvironment in non-small cell lung cancer to understand response rates to checkpoint blockade and radiation. Transl Lung Cancer Res. 2017 Apr; 6(2):148-158. PMID: 28529897.
      View in: PubMed
    61. Fang P, Swanick CW, Pezzi TA, Liao Z, Welsh J, Lin SH, Gomez DR. Outcomes and toxicity following high-dose radiation therapy in 15 fractions for non-small cell lung cancer. Pract Radiat Oncol. 2017 Nov - Dec; 7(6):433-441. PMID: 28428017.
      View in: PubMed
    62. Siegel JA, Sacks B, Pennington CW, Welsh JS. Response to Comments by Drs Hamaoka and Beyea on "The Birth of the Illegitimate Linear No-Threshold Model: An Invalid Paradigm for Estimating Risk Following Low-dose Radiation Exposure". Am J Clin Oncol. 2017 02; 40(1):106-107. PMID: 28106686.
      View in: PubMed
    63. Tang C, Welsh JW, Hong D. Phase I Trial: SABR and Ipilimumab-Response. Clin Cancer Res. 2017 01 01; 23(1):321. PMID: 28049161.
      View in: PubMed
    64. Schoenhals JE, Skrepnik T, Selek U, Cortez MA, Li A, Welsh JW. Optimizing Radiotherapy with Immunotherapeutic Approaches. Adv Exp Med Biol. 2017; 995:53-71. PMID: 28321812.
      View in: PubMed
    65. Brooks ED, Sun B, Zhao L, Komaki R, Liao Z, Jeter M, Welsh JW, O'Reilly MS, Gomez DR, Hahn SM, Heymach JV, Rice DC, Chang JY. Stereotactic Ablative Radiation Therapy is Highly Safe and Effective for Elderly Patients With Early-stage Non-Small Cell Lung Cancer. Int J Radiat Oncol Biol Phys. 2017 07 15; 98(4):900-907. PMID: 28258887.
      View in: PubMed
    66. Logan JK, Tang C, Liao Z, Lee JJ, Heymach JV, Swisher SG, Welsh JW, Zhang J, Lin SH, Gomez DR. Analysis of Factors Affecting Successful Clinical Trial Enrollment in the Context of Three Prospective, Randomized, Controlled Trials. Int J Radiat Oncol Biol Phys. 2017 03 15; 97(4):770-777. PMID: 28244413.
      View in: PubMed
    67. Reddy JP, Tang C, Shih T, Kim B, Kim C, Nguyen QN, Welsh J, Benveniste M, Zhang J, Liao Z, Gomez DR. Influence of Surveillance PET/CT on Detection of Early Recurrence After Definitive Radiation in Stage III Non-small-cell Lung Cancer. Clin Lung Cancer. 2017 03; 18(2):141-148. PMID: 27913215.
      View in: PubMed
    68. Wang X, Schoenhals JE, Li A, Valdecanas DR, Ye H, Zang F, Tang C, Tang M, Liu CG, Liu X, Krishnan S, Allison JP, Sharma P, Hwu P, Komaki R, Overwijk WW, Gomez DR, Chang JY, Hahn SM, Cortez MA, Welsh JW. Suppression of Type I IFN Signaling in Tumors Mediates Resistance to Anti-PD-1 Treatment That Can Be Overcome by Radiotherapy. Cancer Res. 2017 02 15; 77(4):839-850. PMID: 27821490.
      View in: PubMed
    69. Welsh JW, Seyedin SN, Allen PK, Hofstetter WL, Ajani JA, Chang JY, Gomez DR, Amini A, Swisher SG, Blum MA, Younes AI, Nguyen QN, Minsky BD, Erasmus JJ, Lee JH, Bhutani M, Komaki RU. Local Control and Toxicity of a Simultaneous Integrated Boost for Dose Escalation in Locally Advanced Esophageal Cancer: Interim Results from a Prospective Phase I/II Trial. J Thorac Oncol. 2017 02; 12(2):375-382. PMID: 27794500.
      View in: PubMed
    70. Tang C, Welsh JW, de Groot P, Massarelli E, Chang JY, Hess KR, Basu S, Curran MA, Cabanillas ME, Subbiah V, Fu S, Tsimberidou AM, Karp D, Gomez DR, Diab A, Komaki R, Heymach JV, Sharma P, Naing A, Hong DS. Ipilimumab with Stereotactic Ablative Radiation Therapy: Phase I Results and Immunologic Correlates from Peripheral T Cells. Clin Cancer Res. 2017 Mar 15; 23(6):1388-1396. PMID: 27649551.
      View in: PubMed
    71. Chance WW, Nguyen QN, Mehran R, Welsh JW, Gomez DR, Balter P, Komaki R, Liao Z, Chang JY. Stereotactic ablative radiotherapy for adrenal gland metastases: Factors influencing outcomes, patterns of failure, and dosimetric thresholds for toxicity. Pract Radiat Oncol. 2017 May - Jun; 7(3):e195-e203. PMID: 27743801.
      View in: PubMed
    72. Welsh JS. Commentary: Are Children Like Werewolves? Full Moon and Its Association with Sleep and Activity Behaviors in an International Sample of Children. Front Pediatr. 2016; 4:94. PMID: 27629071.
      View in: PubMed
    73. Brooks ED, Schoenhals JE, Tang C, Micevic G, Gomez DR, Chang JY, Welsh JW. Stereotactic Ablative Radiation Therapy Combined With Immunotherapy for Solid Tumors. Cancer J. 2016 Jul-Aug; 22(4):257-66. PMID: 27441745.
      View in: PubMed
    74. Swanick CW, Allen PK, Tao R, Olanrewaju AM, Sutton JR, Lin SH, Welsh J, Das P, Chang JY, Crane CH, Gomez DR. Incidence and predictors of chest wall toxicity after high-dose radiation therapy in 15 fractions. Pract Radiat Oncol. 2017 Jan - Feb; 7(1):63-71. PMID: 27637136.
      View in: PubMed
    75. Schoenhals JE, Seyedin SN, Tang C, Cortez MA, Niknam S, Tsouko E, Chang JY, Hahn SM, Welsh JW. Preclinical Rationale and Clinical Considerations for Radiotherapy Plus Immunotherapy: Going Beyond Local Control. Cancer J. 2016 Mar-Apr; 22(2):130-7. PMID: 27111909.
      View in: PubMed
    76. Cortez MA, Valdecanas D, Niknam S, Peltier HJ, Diao L, Giri U, Komaki R, Calin GA, Gomez DR, Chang JY, Heymach JV, Bader AG, Welsh JW. In Vivo Delivery of miR-34a Sensitizes Lung Tumors to Radiation Through RAD51 Regulation. Mol Ther Nucleic Acids. 2015 Dec 15; 4:e270. PMID: 26670277.
      View in: PubMed
    77. Li P, Wang X, Liu Z, Liu H, Xu T, Wang H, Gomez DR, Nguyen QN, Wang LE, Teng Y, Song Y, Komaki R, Welsh JW, Wei Q, Liao Z. Single Nucleotide Polymorphisms in CBLB, a Regulator of T-Cell Response, Predict Radiation Pneumonitis and Outcomes After Definitive Radiotherapy for Non-Small-Cell Lung Cancer. Clin Lung Cancer. 2016 07; 17(4):253-262.e5. PMID: 26732495.
      View in: PubMed
    78. Cortez MA, Ivan C, Valdecanas D, Wang X, Peltier HJ, Ye Y, Araujo L, Carbone DP, Shilo K, Giri DK, Kelnar K, Martin D, Komaki R, Gomez DR, Krishnan S, Calin GA, Bader AG, Welsh JW. PDL1 Regulation by p53 via miR-34. J Natl Cancer Inst. 2016 Jan; 108(1). PMID: 26577528.
      View in: PubMed
    79. Welsh JS, Howard SP. Comment on "A Novel Thymoma-Associated Immunodeficiency with Increased Naive T Cells and Reduced CD247 Expression". J Immunol. 2015 Oct 15; 195(8):3505. PMID: 26432897.
      View in: PubMed
    80. Socol Y, Welsh JS. Changing Attitude Toward Radiation Carcinogenesis and Prospects for Novel Low-Dose Radiation Treatments. Technol Cancer Res Treat. 2016 12; 15(6):732-736. PMID: 26391015.
      View in: PubMed
    81. Seyedin SN, Schoenhals JE, Lee DA, Cortez MA, Wang X, Niknam S, Tang C, Hong DS, Naing A, Sharma P, Allison JP, Chang JY, Gomez DR, Heymach JV, Komaki RU, Cooper LJ, Welsh JW. Strategies for combining immunotherapy with radiation for anticancer therapy. Immunotherapy. 2015; 7(9):967-980. PMID: 26310908.
      View in: PubMed
    82. Siegel JA, Sacks B, Feinendegen LE, Welsh JS, Fornalski KW, Miller M, Mahn J, Gomez L, Stabin MG, Lewis P, Esposito VJ, Strupczewski A, Pennington CW, Cuttler JM, Rangacharyulu C, Davey C, Sutou S. Comment on "Background Ionizing Radiation and the Risk of Childhood Cancer: A Census-Based Nationwide Cohort Study". Environ Health Perspect. 2015 Aug; 123(8):A200. PMID: 26230545.
      View in: PubMed
    83. Smith BD, Jiang J, Chang JY, Welsh J, Likhacheva A, Buchholz TA, Swisher SG, Shirvani SM. Cost-effectiveness of stereotactic radiation, sublobar resection, and lobectomy for early non-small cell lung cancers in older adults. J Geriatr Oncol. 2015 Jul; 6(4):324-31. PMID: 26094172.
      View in: PubMed
    84. Komaki R, Allen PK, Wei X, Blumenschein GR, Tang X, Lee JJ, Welsh JW, Wistuba II, Liu DD, Hong WK. Adding Erlotinib to Chemoradiation Improves Overall Survival but Not Progression-Free Survival in Stage III Non-Small Cell Lung Cancer. Int J Radiat Oncol Biol Phys. 2015 Jun 01; 92(2):317-24. PMID: 25968826.
      View in: PubMed
    85. Siegel JA, Welsh JS. Does Imaging Technology Cause Cancer? Debunking the Linear No-Threshold Model of Radiation Carcinogenesis. Technol Cancer Res Treat. 2016 Apr; 15(2):249-56. PMID: 25824269.
      View in: PubMed
    86. Socol Y, Welsh JS. Regarding the Credibility of Data Showing an Alleged Association of Cancer with Radiation from CT Scans. Technol Cancer Res Treat. 2016 Feb; 15(1):159-62. PMID: 25616624.
      View in: PubMed
    87. Seyedin SN, Tang C, Welsh JW. Author's view: radiation and immunotherapy as systemic therapy for solid tumors. Oncoimmunology. 2015 Jan; 4(3):e986402. PMID: 25949899.
      View in: PubMed
    88. Parikh NR, Likhacheva A, Pinnix C, Allen PK, Prabhu SS, Guha-Thakurta N, Welsh JW, Brown PD, Chang EL. Prognostic significance of EGFR and KRAS mutations in NSCLC patients with brain metastases treated with radiosurgery†. J Radiosurg SBRT. 2015; 3(3):171-178. PMID: 29296399.
      View in: PubMed
    89. Shirvani SM, Jiang J, Chang JY, Welsh J, Likhacheva A, Buchholz TA, Swisher SG, Smith BD. Lobectomy, sublobar resection, and stereotactic ablative radiotherapy for early-stage non-small cell lung cancers in the elderly. JAMA Surg. 2014 Dec; 149(12):1244-53. PMID: 25321323.
      View in: PubMed
    90. Xu T, Liao Z, O'Reilly MS, Levy LB, Welsh JW, Wang LE, Lin SH, Komaki R, Liu Z, Wei Q, Gomez DR. Serum inflammatory miRNAs predict radiation esophagitis in patients receiving definitive radiochemotherapy for non-small cell lung cancer. Radiother Oncol. 2014 Dec; 113(3):379-84. PMID: 25466375.
      View in: PubMed
    91. Chen L, Gibbons DL, Goswami S, Cortez MA, Ahn YH, Byers LA, Zhang X, Yi X, Dwyer D, Lin W, Diao L, Wang J, Roybal J, Patel M, Ungewiss C, Peng D, Antonia S, Mediavilla-Varela M, Robertson G, Suraokar M, Welsh JW, Erez B, Wistuba II, Chen L, Peng D, Wang S, Ullrich SE, Heymach JV, Kurie JM, Qin FX. Metastasis is regulated via microRNA-200/ZEB1 axis control of tumour cell PD-L1 expression and intratumoral immunosuppression. Nat Commun. 2014 Oct 28; 5:5241. PMID: 25348003.
      View in: PubMed
    92. Welsh JW, Seyedin SN, Cortez MA, Maity A, Hahn SM. Galectin-1 and immune suppression during radiotherapy. Clin Cancer Res. 2014 Dec 15; 20(24):6230-2. PMID: 25348514.
      View in: PubMed
    93. Chance WW, Rice DC, Allen PK, Tsao AS, Fontanilla HP, Liao Z, Chang JY, Tang C, Pan HY, Welsh JW, Mehran RJ, Gomez DR. Hemithoracic intensity modulated radiation therapy after pleurectomy/decortication for malignant pleural mesothelioma: toxicity, patterns of failure, and a matched survival analysis. Int J Radiat Oncol Biol Phys. 2015 Jan 01; 91(1):149-56. PMID: 25442335.
      View in: PubMed
    94. Swanick CW, Lin SH, Sutton J, Naik NS, Allen PK, Levy LB, Liao Z, Welsh JW, Komaki R, Chang JY, Gomez DR. Use of simultaneous radiation boost achieves high control rates in patients with non-small-cell lung cancer who are not candidates for surgery or conventional chemoradiation. Clin Lung Cancer. 2015 Mar; 16(2):156-63. PMID: 25467928.
      View in: PubMed
    95. Gomez DR, Yusuf SW, Munsell MF, Welsh JW, Liao Z, Lin SH, Pan HY, Chang JY, Komaki R, Cox JD, McAleer MF, Grosshans DR. Prospective exploratory analysis of cardiac biomarkers and electrocardiogram abnormalities in patients receiving thoracic radiation therapy with high-dose heart exposure. J Thorac Oncol. 2014 Oct; 9(10):1554-60. PMID: 25521400.
      View in: PubMed
    96. Selek U, Bölükbasi Y, Welsh JW, Topkan E. Intensity-Modulated Radiotherapy versus 3-Dimensional Conformal Radiotherapy Strategies for Locally Advanced Non-Small-Cell Lung Cancer. Balkan Med J. 2014 Dec; 31(4):286-94. PMID: 25667781.
      View in: PubMed
    97. Tang C, Wang X, Soh H, Seyedin S, Cortez MA, Krishnan S, Massarelli E, Hong D, Naing A, Diab A, Gomez D, Ye H, Heymach J, Komaki R, Allison JP, Sharma P, Welsh JW. Combining radiation and immunotherapy: a new systemic therapy for solid tumors? Cancer Immunol Res. 2014 Sep; 2(9):831-8. PMID: 25187273.
      View in: PubMed
    98. Li Q, Swanick CW, Allen PK, Gomez DR, Welsh JW, Liao Z, Balter PA, Chang JY. Stereotactic ablative radiotherapy (SABR) using 70 Gy in 10 fractions for non-small cell lung cancer: exploration of clinical indications. Radiother Oncol. 2014 Aug; 112(2):256-61. PMID: 25108807.
      View in: PubMed
    99. Cuellar SL, Carter BW, Macapinlac HA, Ajani JA, Komaki R, Welsh JW, Lee JH, Swisher SG, Correa AM, Erasmus JJ, Hofstetter WL. Clinical staging of patients with early esophageal adenocarcinoma: does FDG-PET/CT have a role? J Thorac Oncol. 2014 Aug; 9(8):1202-6. PMID: 25157774.
      View in: PubMed
    100. Tang C, Liao Z, Gomez D, Levy L, Zhuang Y, Gebremichael RA, Hong DS, Komaki R, Welsh JW. Lymphopenia association with gross tumor volume and lung V5 and its effects on non-small cell lung cancer patient outcomes. Int J Radiat Oncol Biol Phys. 2014 Aug 01; 89(5):1084-1091. PMID: 25035212.
      View in: PubMed
    101. Chi A, Nguyen NP, Welsh JS, Tse W, Monga M, Oduntan O, Almubarak M, Rogers J, Remick SC, Gius D. Strategies of dose escalation in the treatment of locally advanced non-small cell lung cancer: image guidance and beyond. Front Oncol. 2014; 4:156. PMID: 24999451.
      View in: PubMed
    102. Cortez MA, Valdecanas D, Zhang X, Zhan Y, Bhardwaj V, Calin GA, Komaki R, Giri DK, Quini CC, Wolfe T, Peltier HJ, Bader AG, Heymach JV, Meyn RE, Welsh JW. Therapeutic delivery of miR-200c enhances radiosensitivity in lung cancer. Mol Ther. 2014 Aug; 22(8):1494-1503. PMID: 24791940.
      View in: PubMed
    103. Yu WW, Zhu ZF, Fu XL, Zhao KL, Mao JF, Wu KL, Yang HJ, Fan M, Zhao S, Welsh J. Simultaneous integrated boost intensity-modulated radiotherapy in esophageal carcinoma: early results of a phase II study. Strahlenther Onkol. 2014 Oct; 190(11):979-86. PMID: 24609941.
      View in: PubMed
    104. Welsh JS, Young J, Gupta R. Lionfish on the Loose in the Waters off Saint Vincent. West Indian Med J. 2014 Mar; 63(2):179-81. PMID: 25303255.
      View in: PubMed
    105. Massarelli E, Papadimitrakopoulou V, Welsh J, Tang C, Tsao AS. Immunotherapy in lung cancer. Transl Lung Cancer Res. 2014 Feb; 3(1):53-63. PMID: 25806281.
      View in: PubMed
    106. Pollock J, Welsh JS. Clinical cancer genetics. Part 2: Breast. Am J Clin Oncol. 2014 Feb; 37(1):86-9. PMID: 22307211.
      View in: PubMed
    107. Amini A, Byers LA, Welsh JW, Komaki RU. Progress in the management of limited-stage small cell lung cancer. Cancer. 2014 Mar 15; 120(6):790-8. PMID: 24327434.
      View in: PubMed
    108. Chi A, Wen S, Liao Z, Fowler J, Xu J, Nguyen NP, Welsh JS, Komaki R. What would be the most appropriate a/ß ratio in the setting of stereotactic body radiation therapy for early stage non-small cell lung cancer. Biomed Res Int. 2013; 2013:391021. PMID: 24350266.
      View in: PubMed
    109. Amini A, Ajani J, Komaki R, Allen PK, Minsky BD, Blum M, Xiao L, Suzuki A, Hofstetter W, Swisher S, Gomez D, Liao Z, Lee JH, Bhutani MS, Welsh JW. Factors associated with local-regional failure after definitive chemoradiation for locally advanced esophageal cancer. Ann Surg Oncol. 2014 Jan; 21(1):306-14. PMID: 24197760.
      View in: PubMed
    110. Yang J, Amini A, Williamson R, Zhang L, Zhang Y, Komaki R, Liao Z, Cox J, Welsh J, Court L, Dong L. Automatic contouring of brachial plexus using a multi-atlas approach for lung cancer radiotherapy. Pract Radiat Oncol. 2013 Oct 01; 3(4). PMID: 24273627.
      View in: PubMed
    111. Evans JD, Gomez DR, Chang JY, Gladish GW, Erasmus JJ, Rebueno N, Banchs J, Komaki R, Welsh JW. Cardiac ¹8F-fluorodeoxyglucose uptake on positron emission tomography after thoracic stereotactic body radiation therapy. Radiother Oncol. 2013 Oct; 109(1):82-8. PMID: 24016676.
      View in: PubMed
    112. Shirvani SM, Juloori A, Allen PK, Komaki R, Liao Z, Gomez D, O'Reilly M, Welsh J, Papadimitrakopoulou V, Cox JD, Chang JY. Comparison of 2 common radiation therapy techniques for definitive treatment of small cell lung cancer. Int J Radiat Oncol Biol Phys. 2013 Sep 01; 87(1):139-47. PMID: 23920393.
      View in: PubMed
    113. Francis AM, Sepesi B, Correa AM, Blum MA, Erasmus JJ, Lee JH, Maru DM, Mehran RJ, Rice DC, Roth JA, Vaporciyan AA, Walsh GL, Welsh JW, Swisher SG, Hofstetter WL. The influence of histopathologic tumor viability on long-term survival and recurrence rates following neoadjuvant therapy for esophageal adenocarcinoma. Ann Surg. 2013 Sep; 258(3):500-7. PMID: 24022442.
      View in: PubMed
    114. Welsh JW, McGovern SL, Wefel JS, Komaki R, Brown PD, Soh HE. Reply to v.R. Bhatt et Al and m.C. Chamberlain. J Clin Oncol. 2013 Sep 01; 31(25):3165-6. PMID: 23943829.
      View in: PubMed
    115. Chang JY, Liu YH, Zhu Z, Welsh JW, Gomez DR, Komaki R, Roth JA, Swisher SG. Stereotactic ablative radiotherapy: a potentially curable approach to early stage multiple primary lung cancer. Cancer. 2013 Sep 15; 119(18):3402-10. PMID: 23798353.
      View in: PubMed
    116. Ling H, Spizzo R, Atlasi Y, Nicoloso M, Shimizu M, Redis RS, Nishida N, Gafà R, Song J, Guo Z, Ivan C, Barbarotto E, De Vries I, Zhang X, Ferracin M, Churchman M, van Galen JF, Beverloo BH, Shariati M, Haderk F, Estecio MR, Garcia-Manero G, Patijn GA, Gotley DC, Bhardwaj V, Shureiqi I, Sen S, Multani AS, Welsh J, Yamamoto K, Taniguchi I, Song MA, Gallinger S, Casey G, Thibodeau SN, Le Marchand L, Tiirikainen M, Mani SA, Zhang W, Davuluri RV, Mimori K, Mori M, Sieuwerts AM, Martens JW, Tomlinson I, Negrini M, Berindan-Neagoe I, Foekens JA, Hamilton SR, Lanza G, Kopetz S, Fodde R, Calin GA. CCAT2, a novel noncoding RNA mapping to 8q24, underlies metastatic progression and chromosomal instability in colon cancer. Genome Res. 2013 Sep; 23(9):1446-61. PMID: 23796952.
      View in: PubMed
    117. Murphy CC, Correa AM, Ajani JA, Komaki RU, Welsh JW, Swisher SG, Hofstetter WL. Surgery is an essential component of multimodality therapy for patients with locally advanced esophageal adenocarcinoma. J Gastrointest Surg. 2013 Aug; 17(8):1359-69. PMID: 23715646.
      View in: PubMed
    118. Chi A, Ma P, Fu G, Hobbs G, Welsh JS, Nguyen NP, Jang SY, Dai J, Jin J, Komaki R. Critical structure sparing in stereotactic ablative radiotherapy for central lung lesions: helical tomotherapy vs. volumetric modulated arc therapy. PLoS One. 2013; 8(4):e59729. PMID: 23577071.
      View in: PubMed
    119. Welsh JS. Not all second cancers are secondary. In regard to Mourad et al: "Radiation-induced sarcoma following radiation prophylaxis of heterotopic ossification". Pract Radiat Oncol. 2013 Apr-Jun; 3(2):e35-6. PMID: 24674318.
      View in: PubMed
    120. Benveniste MF, Welsh J, Godoy MC, Betancourt SL, Mawlawi OR, Munden RF. New era of radiotherapy: an update in radiation-induced lung disease. Clin Radiol. 2013 Jun; 68(6):e275-90. PMID: 23473474.
      View in: PubMed
    121. Evans JD, Gomez DR, Amini A, Rebueno N, Allen PK, Martel MK, Rineer JM, Ang KK, McAvoy S, Cox JD, Komaki R, Welsh JW. Aortic dose constraints when reirradiating thoracic tumors. Radiother Oncol. 2013 Mar; 106(3):327-32. PMID: 23453540.
      View in: PubMed
    122. Bhardwaj V, Cascone T, Cortez MA, Amini A, Evans J, Komaki RU, Heymach JV, Welsh JW. Modulation of c-Met signaling and cellular sensitivity to radiation: potential implications for therapy. Cancer. 2013 May 15; 119(10):1768-75. PMID: 23423860.
      View in: PubMed
    123. Yang J, Amini A, Williamson R, Zhang L, Zhang Y, Komaki R, Liao Z, Cox J, Welsh J, Court L, Dong L. Automatic contouring of brachial plexus using a multi-atlas approach for lung cancer radiation therapy. Pract Radiat Oncol. 2013 Oct-Dec; 3(4):e139-47. PMID: 24674411.
      View in: PubMed
    124. Gomez DR, Hong DS, Allen PK, Welsh JS, Mehran RJ, Tsao AS, Liao Z, Bilton SD, Komaki R, Rice DC. Patterns of failure, toxicity, and survival after extrapleural pneumonectomy and hemithoracic intensity-modulated radiation therapy for malignant pleural mesothelioma. J Thorac Oncol. 2013 Feb; 8(2):238-45. PMID: 23247629.
      View in: PubMed
    125. Welsh JW, Komaki R, Amini A, Munsell MF, Unger W, Allen PK, Chang JY, Wefel JS, McGovern SL, Garland LL, Chen SS, Holt J, Liao Z, Brown P, Sulman E, Heymach JV, Kim ES, Stea B. Phase II trial of erlotinib plus concurrent whole-brain radiation therapy for patients with brain metastases from non-small-cell lung cancer. J Clin Oncol. 2013 Mar 01; 31(7):895-902. PMID: 23341526.
      View in: PubMed
    126. Wang HM, Liao ZX, Komaki R, Welsh JW, O'Reilly MS, Chang JY, Zhuang Y, Levy LB, Lu C, Gomez DR. Improved survival outcomes with the incidental use of beta-blockers among patients with non-small-cell lung cancer treated with definitive radiation therapy. Ann Oncol. 2013 May; 24(5):1312-9. PMID: 23300016.
      View in: PubMed
    127. Welsh J, Amini A, Ciura K, Nguyen N, Palmer M, Allen PK, Paolini M, Liao Z, Bluett J, Mohan R, Gomez D, Cox JD, Komaki R, Chang JY. Evaluating proton stereotactic body radiotherapy to reduce chest wall dose in the treatment of lung cancer. Med Dosim. 2013; 38(4):442-447. PMID: 24200220.
      View in: PubMed
    128. Shirvani SM, Jiang J, Chang JY, Welsh JW, Gomez DR, Swisher S, Buchholz TA, Smith BD. Comparative effectiveness of 5 treatment strategies for early-stage non-small cell lung cancer in the elderly. Int J Radiat Oncol Biol Phys. 2012 Dec 01; 84(5):1060-70. PMID: 22975611.
      View in: PubMed
    129. Chang JY, Liu H, Balter P, Komaki R, Liao Z, Welsh J, Mehran RJ, Roth JA, Swisher SG. Clinical outcome and predictors of survival and pneumonitis after stereotactic ablative radiotherapy for stage I non-small cell lung cancer. Radiat Oncol. 2012 Sep 10; 7:152. PMID: 22963661.
      View in: PubMed
    130. Byers LA, Wang J, Nilsson MB, Fujimoto J, Saintigny P, Yordy J, Giri U, Peyton M, Fan YH, Diao L, Masrorpour F, Shen L, Liu W, Duchemann B, Tumula P, Bhardwaj V, Welsh J, Weber S, Glisson BS, Kalhor N, Wistuba II, Girard L, Lippman SM, Mills GB, Coombes KR, Weinstein JN, Minna JD, Heymach JV. Proteomic profiling identifies dysregulated pathways in small cell lung cancer and novel therapeutic targets including PARP1. Cancer Discov. 2012 Sep; 2(9):798-811. PMID: 22961666.
      View in: PubMed
    131. Skinner HD, McCurdy MR, Echeverria AE, Lin SH, Welsh JW, O'Reilly MS, Hofstetter WL, Ajani JA, Komaki R, Cox JD, Sandulache VC, Myers JN, Guerrero TM. Metformin use and improved response to therapy in esophageal adenocarcinoma. Acta Oncol. 2013 Jun; 52(5):1002-9. PMID: 22950385.
      View in: PubMed
    132. Taketa T, Correa AM, Suzuki A, Blum MA, Chien P, Lee JH, Welsh J, Lin SH, Maru DM, Erasmus JJ, Bhutani MS, Weston B, Rice DC, Vaporciyan AA, Hofstetter WL, Swisher SG, Ajani JA. Outcome of trimodality-eligible esophagogastric cancer patients who declined surgery after preoperative chemoradiation. Oncology. 2012; 83(5):300-4. PMID: 22964903.
      View in: PubMed
    133. Bhardwaj V, Zhan Y, Cortez MA, Ang KK, Molkentine D, Munshi A, Raju U, Komaki R, Heymach JV, Welsh J. C-Met inhibitor MK-8003 radiosensitizes c-Met-expressing non-small-cell lung cancer cells with radiation-induced c-Met-expression. J Thorac Oncol. 2012 Aug; 7(8):1211-7. PMID: 22617250.
      View in: PubMed
    134. Hayashi Y, Xiao L, Suzuki A, Blum MA, Sabloff B, Taketa T, Maru DM, Welsh J, Lin SH, Weston B, Lee JH, Bhutani MS, Hofstetter WL, Swisher SG, Ajani JA. A nomogram associated with high probability of malignant nodes in the surgical specimen after trimodality therapy of patients with oesophageal cancer. Eur J Cancer. 2012 Dec; 48(18):3396-404. PMID: 22853875.
      View in: PubMed
    135. Ajani JA, Correa AM, Hofstetter WL, Rice DC, Blum MA, Suzuki A, Taketa T, Welsh J, Lin SH, Lee JH, Bhutani MS, Ross WA, Maru DM, Macapinlac HA, Erasmus J, Komaki R, Mehran RJ, Vaporciyan AA, Swisher SG. Clinical parameters model for predicting pathologic complete response following preoperative chemoradiation in patients with esophageal cancer. Ann Oncol. 2012 Oct; 23(10):2638-42. PMID: 22831985.
      View in: PubMed
    136. Chi A, Liao Z, Nguyen NP, Xu J, Welsh JS, Jang SY, Howe C, Komaki R. Dosimetric selection for helical tomotherapy based stereotactic ablative radiotherapy for early-stage non-small cell lung cancer or lung metastases. PLoS One. 2012; 7(4):e35809. PMID: 22558228.
      View in: PubMed
    137. Chi A, Nguyen NP, Xu J, Ji M, Tang J, Jin J, Ong ES, Welsh JS. Correlation of three different approaches of small bowel delineation and acute lower gastrointestinal toxicity in adjuvant pelvic intensity-modulated radiation therapy for endometrial cancer. Technol Cancer Res Treat. 2012 Aug; 11(4):353-9. PMID: 22475067.
      View in: PubMed
    138. Amini A, Xiao L, Allen PK, Suzuki A, Hayashi Y, Liao Z, Hofstetter W, Crane C, Komaki R, Bhutani MS, Lee JH, Ajani JA, Welsh J. Celiac node failure patterns after definitive chemoradiation for esophageal cancer in the modern era. Int J Radiat Oncol Biol Phys. 2012 Jun 01; 83(2):e231-9. PMID: 22436793.
      View in: PubMed
    139. Yin M, Liao Z, Yuan X, Guan X, O'Reilly MS, Welsh J, Wang LE, Wei Q. Polymorphisms of the vascular endothelial growth factor gene and severe radiation pneumonitis in non-small cell lung cancer patients treated with definitive radiotherapy. Cancer Sci. 2012 May; 103(5):945-50. PMID: 22320189.
      View in: PubMed
    140. Amini A, Yang J, Williamson R, McBurney ML, Erasmus J, Allen PK, Karhade M, Komaki R, Liao Z, Gomez D, Cox J, Dong L, Welsh J. Dose constraints to prevent radiation-induced brachial plexopathy in patients treated for lung cancer. Int J Radiat Oncol Biol Phys. 2012 Mar 01; 82(3):e391-8. PMID: 22284035.
      View in: PubMed
    141. Rong Y, Yadav P, Welsh JS, Fahner T, Paliwal B. Postmastectomy radiotherapy with integrated scar boost using helical tomotherapy. Med Dosim. 2012; 37(3):233-9. PMID: 22365416.
      View in: PubMed
    142. Suzuki A, Xiao L, Hayashi Y, Blum MA, Welsh JW, Lin SH, Lee JH, Bhutani MS, Weston B, Maru DM, Rice DC, Swisher SG, Hofstetter WL, Erasmus J, Ajani JA. Nomograms for prognostication of outcome in patients with esophageal and gastroesophageal carcinoma undergoing definitive chemoradiotherapy. Oncology. 2012; 82(2):108-13. PMID: 22328056.
      View in: PubMed
    143. Cortez MA, Welsh JW, Calin GA. Circulating microRNAs as noninvasive biomarkers in breast cancer. Recent Results Cancer Res. 2012; 195:151-61. PMID: 22527502.
      View in: PubMed
    144. Harvin JA, Lahat G, Correa AM, Lee J, Maru D, Ajani J, Marom EM, Welsh J, Bhutani MS, Walsh G, Roth J, Mehran R, Vaporciyan A, Rice D, Swisher S, Hofstetter W. Neoadjuvant chemoradiotherapy followed by surgery for esophageal adenocarcinoma: significance of microscopically positive circumferential radial margins. J Thorac Cardiovasc Surg. 2012 Feb; 143(2):412-20. PMID: 22172216.
      View in: PubMed
    145. Hayashi Y, Correa AM, Hofstetter WL, Vaporciyan AA, Mehran RJ, Rice DC, Suzuki A, Lee JH, Bhutani MS, Welsh J, Lin SH, Maru DM, Swisher SG, Ajani JA. Patients with high body mass index tend to have lower stage of esophageal carcinoma at diagnosis. Dis Esophagus. 2012 Sep-Oct; 25(7):614-22. PMID: 22150920.
      View in: PubMed
    146. Welsh J, Settle SH, Amini A, Xiao L, Suzuki A, Hayashi Y, Hofstetter W, Komaki R, Liao Z, Ajani JA. Failure patterns in patients with esophageal cancer treated with definitive chemoradiation. Cancer. 2012 May 15; 118(10):2632-40. PMID: 22565611.
      View in: PubMed
    147. Kim JY, Correa AM, Vaporciyan AA, Roth JA, Mehran RJ, Walsh GL, Rice DC, Ajani JA, Maru DM, Bhutani MS, Welsh J, Marom EM, Swisher SG, Hofstetter WL. Does the timing of esophagectomy after chemoradiation affect outcome? Ann Thorac Surg. 2012 Jan; 93(1):207-12; discussion 212-3. PMID: 21962263.
      View in: PubMed
    148. Nag S, Demanes DJ, Hagan M, Rivard MJ, Thomadsen BR, Welsh JS, Williamson JF. Definition of medical event is to be based on the total source strength for evaluation of permanent prostate brachytherapy: A report from the American Society for Radiation Oncology. Pract Radiat Oncol. 2011 Oct; 1(4):218-223. PMID: 24174998.
      View in: PubMed
    149. Yadav P, Kozak K, Tolakanahalli R, Ramasubramanian V, Paliwal BR, Welsh JS, Rong Y. Adaptive planning using megavoltage fan-beam CT for radiation therapy with testicular shielding. Med Dosim. 2012; 37(2):157-62. PMID: 21925866.
      View in: PubMed
    150. Chi A, Tomé WA, Fowler J, Komaki R, Nguyen NP, Mehta MP, Welsh JS. Stereotactic body radiation therapy in non-small-cell lung cancer: linking radiobiological modeling and clinical outcome. Am J Clin Oncol. 2011 Aug; 34(4):432-41. PMID: 20539207.
      View in: PubMed
    151. Welsh J, Amini A, Likhacheva A, Erasmus J J, Gomez D, Davila M, Mehran RJ, Komaki R, Liao Z, Hofstetter WL, Lee H J, Bhutani MS, Ajani JA. Update: modern approaches to the treatment of localized esophageal cancer. Curr Oncol Rep. 2011 Jun; 13(3):157-67. PMID: 21365188.
      View in: PubMed
    152. Pollock J, Welsh JS. Clinical cancer genetics: Part I: Gastrointestinal. Am J Clin Oncol. 2011 Jun; 34(3):332-6. PMID: 20859198.
      View in: PubMed
    153. Ajani JA, Blum MA, Welsh J, Hofstetter WL, Swisher SG. Celebrate or calibrate? We say calibrate. J Clin Oncol. 2011 Jul 01; 29(19):2732; author reply 2732-3. PMID: 21606421.
      View in: PubMed
    154. Welsh J, Gomez D, Palmer MB, Riley BA, Mayankkumar AV, Komaki R, Dong L, Zhu XR, Likhacheva A, Liao Z, Hofstetter WL, Ajani JA, Cox JD. Intensity-modulated proton therapy further reduces normal tissue exposure during definitive therapy for locally advanced distal esophageal tumors: a dosimetric study. Int J Radiat Oncol Biol Phys. 2011 Dec 01; 81(5):1336-42. PMID: 21470796.
      View in: PubMed
    155. Suzuki A, Xiao L, Hayashi Y, Macapinlac HA, Welsh J, Lin SH, Lee JH, Bhutani MS, Maru DM, Hofstetter WL, Swisher SG, Ajani JA. Prognostic significance of baseline positron emission tomography and importance of clinical complete response in patients with esophageal or gastroesophageal junction cancer treated with definitive chemoradiotherapy. Cancer. 2011 Nov 01; 117(21):4823-33. PMID: 21456015.
      View in: PubMed
    156. Rong Y, Welsh JS. Dosimetric and clinical review of helical tomotherapy. Expert Rev Anticancer Ther. 2011 Feb; 11(2):309-20. PMID: 21342048.
      View in: PubMed
    157. Chi A, Jang SY, Welsh JS, Nguyen NP, Ong E, Gobar L, Komaki R. Feasibility of helical tomotherapy in stereotactic body radiation therapy for centrally located early stage non?small-cell lung cancer or lung metastases. Int J Radiat Oncol Biol Phys. 2011 Nov 01; 81(3):856-62. PMID: 21255942.
      View in: PubMed
    158. Rong Y, Tang G, Welsh JS, Mohiuddin MM, Paliwal B, Yu CX. Helical tomotherapy versus single-arc intensity-modulated arc therapy: a collaborative dosimetric comparison between two institutions. Int J Radiat Oncol Biol Phys. 2011 Sep 01; 81(1):284-96. PMID: 21236598.
      View in: PubMed
    159. Welsh JS. Contagious cancer. Oncologist. 2011; 16(1):1-4. PMID: 21212437.
      View in: PubMed
    160. Turner LM, Howard JA, Dehghanpour P, Barrett RD, Rebueno N, Palmer M, Vedam S, Klopp A, Komaki R, Welsh JW. Exploring the feasibility of dose escalation positron emission tomography-positive disease with intensity-modulated radiation therapy and the effects on normal tissue structures for thoracic malignancies. Med Dosim. 2011; 36(4):383-8. PMID: 21144734.
      View in: PubMed
    161. Welsh J, Palmer MB, Ajani JA, Liao Z, Swisher SG, Hofstetter WL, Allen PK, Settle SH, Gomez D, Likhacheva A, Cox JD, Komaki R. Esophageal cancer dose escalation using a simultaneous integrated boost technique. Int J Radiat Oncol Biol Phys. 2012 Jan 01; 82(1):468-74. PMID: 21123005.
      View in: PubMed
    162. Rong Y, Welsh J. Basics of particle therapy II biologic and dosimetric aspects of clinical hadron therapy. Am J Clin Oncol. 2010 Dec; 33(6):646-9. PMID: 20395789.
      View in: PubMed
    163. Rong Y, Yadav P, Paliwal B, Shang L, Welsh JS. A planning study for palliative spine treatment using StatRT and megavoltage CT simulation. J Appl Clin Med Phys. 2010 Oct 30; 12(1):3348. PMID: 21330983.
      View in: PubMed
    164. Rong Y, Welsh JS. Surface applicator calibration and commissioning of an electronic brachytherapy system for nonmelanoma skin cancer treatment. Med Phys. 2010 Oct; 37(10):5509-17. PMID: 21089786.
      View in: PubMed
    165. Rong Y, Paliwal B, Howard SP, Welsh J. Treatment planning for pulsed reduced dose-rate radiotherapy in helical tomotherapy. Int J Radiat Oncol Biol Phys. 2011 Mar 01; 79(3):934-42. PMID: 20884127.
      View in: PubMed
    166. Platta CS, Mackay C, Welsh JS. Pituitary adenoma: a radiotherapeutic perspective. Am J Clin Oncol. 2010 Aug; 33(4):408-19. PMID: 19687730.
      View in: PubMed
    167. Welsh J, Thomas J, Shah D, Allen PK, Wei X, Mitchell K, Gao S, Balter P, Komaki R, Chang JY. Obesity increases the risk of chest wall pain from thoracic stereotactic body radiation therapy. Int J Radiat Oncol Biol Phys. 2011 Sep 01; 81(1):91-6. PMID: 20542388.
      View in: PubMed
    168. Adkison JB, Tomé W, Seo S, Richards GM, Robins HI, Rassmussen K, Welsh JS, Mahler PA, Howard SP. Reirradiation of large-volume recurrent glioma with pulsed reduced-dose-rate radiotherapy. Int J Radiat Oncol Biol Phys. 2011 Mar 01; 79(3):835-41. PMID: 20472350.
      View in: PubMed
    169. Nguyen NP, Bishop M, Borok TJ, Welsh J, Hamilton R, Cohen D, Nguyen LM, Vincent VH. Pattern of failure following chemoradiation for locally advanced non-small cell lung cancer: potential role for stereotactic body radiotherapy. Anticancer Res. 2010 Mar; 30(3):953-61. PMID: 20393019.
      View in: PubMed
    170. Potters L, Kavanagh B, Galvin JM, Hevezi JM, Janjan NA, Larson DA, Mehta MP, Ryu S, Steinberg M, Timmerman R, Welsh JS, Rosenthal SA. American Society for Therapeutic Radiology and Oncology (ASTRO) and American College of Radiology (ACR) practice guideline for the performance of stereotactic body radiation therapy. Int J Radiat Oncol Biol Phys. 2010 Feb 01; 76(2):326-32. PMID: 20117285.
      View in: PubMed
    171. Welsh JW, Mahadevan D, Ellsworth R, Cooke L, Bearss D, Stea B. The c-Met receptor tyrosine kinase inhibitor MP470 radiosensitizes glioblastoma cells. Radiat Oncol. 2009 Dec 22; 4:69. PMID: 20028557.
      View in: PubMed
    172. Welsh JW, Ellsworth RK, Kumar R, Fjerstad K, Martinez J, Nagel RB, Eschbacher J, Stea B. Rad51 protein expression and survival in patients with glioblastoma multiforme. Int J Radiat Oncol Biol Phys. 2009 Jul 15; 74(4):1251-5. PMID: 19545791.
      View in: PubMed
    173. Nguyen NP, Borok TL, Welsh J, Vinh-Hung V. Safety and effectiveness of vascular endoprosthesis for malignant superior vena cava syndrome. Thorax. 2009 Feb; 64(2):174-8. PMID: 19176843.
      View in: PubMed
    174. Welsh JS. Clinical, technical, and basic science progress in helical tomotherapy--the pace continues to accelerate. Technol Cancer Res Treat. 2009 Feb; 8(1):1-2. PMID: 19166236.
      View in: PubMed
    175. Hui SK, Verneris MR, Froelich J, Dusenbery K, Welsh JS. Multimodality image guided total marrow irradiation and verification of the dose delivered to the lung, PTV, and thoracic bone in a patient: a case study. Technol Cancer Res Treat. 2009 Feb; 8(1):23-8. PMID: 19166239.
      View in: PubMed
    176. Welsh JS. Helical tomotherapy: a fascinating technological concept that has matured into clinical reality. Technol Cancer Res Treat. 2008 Dec; 7(6):415-6. PMID: 19044319.
      View in: PubMed
    177. Rong Y, Fahner T, Welsh JS. Hypofractionated breast and chest wall irradiation using simultaneous in-field boost IMRT delivered via helical tomotherapy. Technol Cancer Res Treat. 2008 Dec; 7(6):433-9. PMID: 19044322.
      View in: PubMed
    178. Olsen CC, Welsh J, Kavanagh BD, Franklin W, McCarter M, Cardenes HR, Gaspar LE, Schefter TE. Microscopic and macroscopic tumor and parenchymal effects of liver stereotactic body radiotherapy. Int J Radiat Oncol Biol Phys. 2009 Apr 01; 73(5):1414-24. PMID: 18990508.
      View in: PubMed
    179. Nguyen NP, Vos P, Lee H, Borok TL, Karlsson U, Martinez T, Welsh J, Cohen D, Hamilton R, Nguyen N, Nguyen LM, Vinh-Hung V. Impact of tumor board recommendations on treatment outcome for locally advanced head and neck cancer. Oncology. 2008; 75(3-4):186-91. PMID: 18841033.
      View in: PubMed
    180. Welsh JS. Basics of particle therapy: introduction to hadrons. Am J Clin Oncol. 2008 Oct; 31(5):493-5. PMID: 18838888.
      View in: PubMed
    181. Nguyen NP, Garland L, Welsh J, Hamilton R, Cohen D, Vinh-Hung V. Can stereotactic fractionated radiation therapy become the standard of care for early stage non-small cell lung carcinoma. Cancer Treat Rev. 2008 Dec; 34(8):719-27. PMID: 18657910.
      View in: PubMed
    182. Welsh JS. A potential means of investigating the role of luteinizing hormone in the pathogenesis of Alzheimer disease. Clin Med Res. 2008 May; 6(1):1-2. PMID: 18591369.
      View in: PubMed
    183. Richards GM, Tomé WA, Robins HI, Stewart JA, Welsh JS, Mahler PA, Howard SP. Pulsed reduced dose-rate radiotherapy: a novel locoregional retreatment strategy for breast cancer recurrence in the previously irradiated chest wall, axilla, or supraclavicular region. Breast Cancer Res Treat. 2009 Mar; 114(2):307-13. PMID: 18389365.
      View in: PubMed
    184. Speer TW, Welsh JS. Will radioimmunotherapy survive? Clin Adv Hematol Oncol. 2008 Apr; 6(4):233, 237. PMID: 18524050.
      View in: PubMed
    185. Hong TS, Welsh JS, Ritter MA, Harari PM, Jaradat H, Mackie TR, Mehta MP. Megavoltage computed tomography: an emerging tool for image-guided radiotherapy. Am J Clin Oncol. 2007 Dec; 30(6):617-23. PMID: 18091057.
      View in: PubMed
    186. Welsh JS, Limmer JP. Dosimetric concerns regarding the 4-field box technique. Am J Clin Oncol. 2007 Dec; 30(6):666. PMID: 18091067.
      View in: PubMed
    187. Welsh JS, Limmer JP. Image-guided hypofractionated simultaneous in-field boost breast IMRT: in regard to Freedman et al. (Int J Radiat Oncol Biol Phys 2007;68:347-353). Int J Radiat Oncol Biol Phys. 2007 Nov 01; 69(3):962; author reply 963. PMID: 17889278.
      View in: PubMed
    188. Welsh JS. Beta decay in science and medicine. Am J Clin Oncol. 2007 Aug; 30(4):437-9. PMID: 17762446.
      View in: PubMed
    189. Welsh JS. Radiographically identified necrosis after 90Y microsphere brachytherapy: a new standard for oncologic response assessment? AJR Am J Roentgenol. 2007 Mar; 188(3):765-7. PMID: 17312066.
      View in: PubMed
    190. Welsh J, Sanan A, Gabayan AJ, Green SB, Lustig R, Burri S, Kwong E, Stea B. GliaSite brachytherapy boost as part of initial treatment of glioblastoma multiforme: a retrospective multi-institutional pilot study. Int J Radiat Oncol Biol Phys. 2007 May 01; 68(1):159-65. PMID: 17331666.
      View in: PubMed
    191. Welsh JS, Howard A, Hong HY, Lucas D, Ho T, Reding DJ. Synchronous bilateral breast mucosa-associated lymphoid tissue lymphomas addressed with primary radiation therapy. Am J Clin Oncol. 2006 Dec; 29(6):634-5. PMID: 17149003.
      View in: PubMed
    192. Welsh JS. Electron capture. Am J Clin Oncol. 2006 Dec; 29(6):540-2. PMID: 17148987.
      View in: PubMed
    193. Welsh JS, Lock M, Harari PM, Tomé WA, Fowler J, Mackie TR, Ritter M, Kapatoes J, Forrest L, Chappell R, Paliwal B, Mehta MP. Clinical implementation of adaptive helical tomotherapy: a unique approach to image-guided intensity modulated radiotherapy. Technol Cancer Res Treat. 2006 Oct; 5(5):465-79. PMID: 16981789.
      View in: PubMed
    194. Weiss SE, O'Connor L, Welsh JS. Refinement of radiation therapy based on PET data in an adult with Langerhans cell histiocytosis of soft tissues. Clin Adv Hematol Oncol. 2006 Apr; 4(4):290-2; discussion 292-4. PMID: 16775877.
      View in: PubMed
    195. Khuntia D, Jaradat H, Orton N, Tomé W, Mehta MP, Welsh JS. Helical tomotherapy as a means of administering total or partial scalp irradiation: In regards to Bedford et al. (Int J Radiat Oncol Biol Phys 2005;62:1549-1558). Int J Radiat Oncol Biol Phys. 2006 Mar 15; 64(4):1288-9; author reply 1289-90. PMID: 16504768.
      View in: PubMed
    196. Welsh JS. Beta radiation. Oncologist. 2006 Feb; 11(2):181-3. PMID: 16476838.
      View in: PubMed
    197. Welsh JS. Quarks, leptons, fermions, and bosons--the subatomic world of radiation therapy. Oncologist. 2006 Jan; 11(1):62-4. PMID: 16401714.
      View in: PubMed
    198. Welsh JS, Kennedy AS, Thomadsen B. Selective Internal Radiation Therapy (SIRT) for liver metastases secondary to colorectal adenocarcinoma. Int J Radiat Oncol Biol Phys. 2006; 66(2 Suppl):S62-73. PMID: 16979443.
      View in: PubMed
    199. Welsh JS, Mehta MP, Mackie TR, Orton N, Jaradat H, Khuntia D, Tomé W. Helical tomotherapy as a means of delivering scalp-sparing whole brain radiation therapy. Technol Cancer Res Treat. 2005 Dec; 4(6):661-2; author reply 662. PMID: 16292886.
      View in: PubMed
    200. Hui SK, Kapatoes J, Fowler J, Henderson D, Olivera G, Manon RR, Gerbi B, Mackie TR, Welsh JS. Feasibility study of helical tomotherapy for total body or total marrow irradiation. Med Phys. 2005 Oct; 32(10):3214-24. PMID: 16279075.
      View in: PubMed
    201. Duffy BM, Manon R, Patel RR, Welsh JS. A case of Gorham's disease with chylothorax treated curatively with radiation therapy. Clin Med Res. 2005 May; 3(2):83-6. PMID: 16012125.
      View in: PubMed
    202. Welsh JS, Limmer JP, Howard SP, Diamond D, Harari PM, Tome W. Precautions in the use of intensity-modulated radiation therapy. Technol Cancer Res Treat. 2005 Apr; 4(2):203-10. PMID: 15773789.
      View in: PubMed
    203. Orton N, Jaradat H, Welsh J, Tomé W. Total scalp irradiation using helical tomotherapy. Med Dosim. 2005; 30(3):162-8. PMID: 16112468.
      View in: PubMed
    204. Hui SK, Das RK, Kapatoes J, Oliviera G, Becker S, Odau H, Fenwick JD, Patel R, Kuske R, Mehta M, Paliwal B, Mackie TR, Fowler JF, Welsh JS. Helical tomotherapy as a means of delivering accelerated partial breast irradiation. Technol Cancer Res Treat. 2004 Dec; 3(6):639-46. PMID: 15560722.
      View in: PubMed
    205. Potters L, Steinberg M, Rose C, Timmerman R, Ryu S, Hevezi JM, Welsh J, Mehta M, Larson DA, Janjan NA. American Society for Therapeutic Radiology and Oncology and American College of Radiology practice guideline for the performance of stereotactic body radiation therapy. Int J Radiat Oncol Biol Phys. 2004 Nov 15; 60(4):1026-32. PMID: 15519771.
      View in: PubMed
    206. Welsh JS, Berta C, Borzillary S, Sam C, Shickell D, Nobile L, Greenberg M, Weiss S, Detorie N. Fiducial markers implanted during prostate brachytherapy for guiding conformal external beam radiation therapy. Technol Cancer Res Treat. 2004 Aug; 3(4):359-64. PMID: 15270586.
      View in: PubMed
    207. Tomé WA, Welsh J, Fowler JF. The effect of fraction time in intensity modulated radiotherapy: theoretical and experimental evaluation of an optimization problem (the real conclusions): in regard to Mu et al. Radiotherapy on Oncology 2003; 68: 181-87. Radiother Oncol. 2004 Jul; 72(1):113-4; author reply 114-5. PMID: 15236883.
      View in: PubMed
    208. Fowler JF, Welsh JS, Howard SP. Loss of biological effect in prolonged fraction delivery. Int J Radiat Oncol Biol Phys. 2004 May 01; 59(1):242-9. PMID: 15093921.
      View in: PubMed
    209. Welsh JS, Bradley K, Ruchala KJ, Mackie TR, Mañon R, Patel R, Wiederholt P, Lock M, Hui S, Mehta MP. Megavoltage computed tomography imaging: a potential tool to guide and improve the delivery of thoracic radiation therapy. Clin Lung Cancer. 2004 Mar; 5(5):303-6. PMID: 15086969.
      View in: PubMed
    210. Welsh JS. Thymoma and subsequent cancers. Int J Cancer. 2004 Jan 10; 108(2):327. PMID: 14639623.
      View in: PubMed
    211. Song DY, Jones RJ, Welsh JS, Haulk TL, Korman LT, Noga S, Goodman S, Herman M, Mann R, Marcellus D, Vogelsang G, Ambinder RF, Abrams RA. Phase I study of escalating doses of low-dose-rate, locoregional irradiation preceding Cytoxan-TBI for patients with chemotherapy-resistant non-Hodgkin's or Hodgkin's lymphoma. Int J Radiat Oncol Biol Phys. 2003 Sep 01; 57(1):166-71. PMID: 12909229.
      View in: PubMed
    212. Welsh JS, Howard SP, Fowler JF. Dose rate in external beam radiotherapy for prostate cancer: an overlooked confounding variable? Urology. 2003 Aug; 62(2):204-6. PMID: 12893319.
      View in: PubMed
    213. Welsh JS, Thurman SA, Howard SP. Thymoma and multiple malignancies: a case of five synchronous neoplasms and literature review. Clin Med Res. 2003 Jul; 1(3):227-32. PMID: 15931312.
      View in: PubMed
    214. Welsh JS, Thurman SA, Borzillary S, Schwartz CL, Howard SP. Sm-153 EDTMP for recurrent metastatic osteosarcoma. Clin Adv Hematol Oncol. 2003 Mar; 1(3):181-3; discussion 183. PMID: 16224400.
      View in: PubMed
    215. Welsh JS, Patel RR, Ritter MA, Harari PM, Mackie TR, Mehta MP. Helical tomotherapy: an innovative technology and approach to radiation therapy. Technol Cancer Res Treat. 2002 Aug; 1(4):311-6. PMID: 12625791.
      View in: PubMed
    216. Song DY, Lawrie WT, Abrams RA, Kafonek DR, Bayless TM, Welsh JS, DeWeese TL. Acute and late radiotherapy toxicity in patients with inflammatory bowel disease. Int J Radiat Oncol Biol Phys. 2001 Oct 01; 51(2):455-9. PMID: 11567821.
      View in: PubMed
    217. Welsh JS, Howard SP. Acute myelogenous leukemia after exposure to strontium-89 for the treatment of adenocarcinoma of the prostate. Cancer. 2000 Jul 01; 89(1):226-7. PMID: 10897031.
      View in: PubMed
    218. Xu L, Corcoran RB, Welsh JW, Pennica D, Levine AJ. WISP-1 is a Wnt-1- and beta-catenin-responsive oncogene. Genes Dev. 2000 Mar 01; 14(5):585-95. PMID: 10716946.
      View in: PubMed
    219. Welsh JS, Yanez MH, Chin BB, Howard SP. Indium-111 capromab pendetide (ProstaScint) images before and after salvage radiation therapy. Clin Nucl Med. 1999 Dec; 24(12):983. PMID: 10595485.
      View in: PubMed
    220. Welsh JS, Torre TG, DeWeese TL, O'Reilly S. Radiation myositis. Ann Oncol. 1999 Sep; 10(9):1105-8. PMID: 10572610.
      View in: PubMed
    221. Chin BB, Welsh JS, Kleinberg L, Ettinger D, White P. Nonsegmental ventilation-perfusion scintigraphy mismatch after radiation therapy. Clin Nucl Med. 1999 Jan; 24(1):54-6. PMID: 9890495.
      View in: PubMed
    222. Pennica D, Swanson TA, Welsh JW, Roy MA, Lawrence DA, Lee J, Brush J, Taneyhill LA, Deuel B, Lew M, Watanabe C, Cohen RL, Melhem MF, Finley GG, Quirke P, Goddard AD, Hillan KJ, Gurney AL, Botstein D, Levine AJ. WISP genes are members of the connective tissue growth factor family that are up-regulated in wnt-1-transformed cells and aberrantly expressed in human colon tumors. Proc Natl Acad Sci U S A. 1998 Dec 08; 95(25):14717-22. PMID: 9843955.
      View in: PubMed
    223. Bornside GH, Welsh JS, Crowder VH, Cohn I. Disposable hexachlorophene impregnated polyurethane scrub sponges: a clinical bacteriologic study. Ann Surg. 1967 Jul; 166(1):129-36. PMID: 6028833.
      View in: PubMed
    224. In vivo delivery of miR-34a sensitizes lung tumors to radiation through RAD51 regulation. Molecular Therapy - Nucleic Acids. 4.
    225. OncoImmunology. 4:1-3.
    226. Simultaneous integrated boost intensity-modulated radiotherapy in esophageal carcinoma - Early results of a phase II study. Strahlentherapie und Onkologie. 1-7.
    227. Cost-effectiveness of stereotactic radiation, sublobar resection, and lobectomy for early non-small cell lung cancers in older adults. Journal of Geriatric Oncology.
    228. Incidence and predictors of chest wall toxicity after high-dose radiation therapy in 15 fractions. Practical Radiation Oncology. 7:63-71.
    229. Stereotactic ablative radiotherapy for adrenal gland metastases. Practical Radiation Oncology.
    230. Influence of Surveillance PET/CT on Detection of Early Recurrence After Definitive Radiation in Stage III Non-small-cell Lung Cancer. Clinical Lung Cancer.
    231. Immunotherapy in lung cancer. Translational Lung Cancer Research. 3:53-63.
    232. Strategies for combining immunotherapy with radiation for anticancer therapy. Immunotherapy. 7:967-980.
    233. Intensity-modulated radiotherapy versus 3-dimensional conformal radiotherapy strategies for locally advanced non-small-cell lung cancer. Balkan Medical Journal. 31:286-294.
    234. Automatic contouring of brachial plexus using a multi-atlas approach for lung cancer radiation therapy. Practical Radiation Oncology. 3.
    235. Differential DNA methylation analysis of breast cancer reveals the impact of immune signaling in radiation therapy. Breast Diseases. 26:82-83.
    236. Single Nucleotide Polymorphisms in CBLB, a Regulator of T-Cell Response, Predict Radiation Pneumonitis and Outcomes After Definitive Radiotherapy for Non-Small-Cell Lung Cancer. Clinical Lung Cancer.
    237. The development of PDGF receptor inhibitors for the treatment of Glioma. Letters in Drug Design and Discovery. 7:290-299.
    238. Preclinical rationale and clinical considerations for radiotherapy plus immunotherapy going beyond local control. Cancer Journal (United States). 22:130-137.
    239. Planning Target Volume D95 and Mean Dose Should Be Considered for Optimal Local Control for Stereotactic Ablative Radiation Therapy. International Journal of Radiation Oncology Biology Physics.
    240. Stereotactic ablative radiation therapy combined with immunotherapy for solid tumors. Cancer Journal (United States). 22:257-266.
    WELSH's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    _
    Co-Authors Expand Description
    _
    Similar People Expand Description
    _
    Same Department Expand Description